Hbk Investments L P
Source: SEC Form 13F · as of Mar 2026Hbk Investments L P holds 8 biotech & pharma companies tracked by BioSniper, totaling $696.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
8
Total value held
$696.1M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Arcellx, Inc. (ACLX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ACLXArcellx, Inc. | 2,278,517 | $261.6M |
| TERNTerns Pharmaceuticals, Inc. | 2,950,000 | $155.5M |
| APLSApellis Pharmaceuticals, Inc. | 3,550,000 | $142.8M |
| FOLDAMICUS THERAPEUTICS, INC. | 8,783,448 | $127.0M |
| GMOptec International, Inc. | 58,993 | $4.4M |
| CCXIChemoCentryx, Inc. | 300,000 | $3.0M |
| PFEPFIZER INC | 41,378 | $1.2M |
| ALHCAlignment Healthcare Inc. | 32,600 | $574K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.